TerminatedNot Applicable

IRIS-BioFreedom Cohort in the IRIS-DES Registry

Stopped: Funding issue

South Korea218 participantsStarted 2019-05-20

Plain-language summary

The objective of this study is to evaluate effectiveness and safety of BIOFREEDOM™ FAMILY stent in the "real world" daily practice as compared with other drug-eluting stents.

Who can participate

Age range19 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age 19 and more * Patient with BIOFREEDOM™ FAMILY stent * Written consent Exclusion Criteria: * Intervention with BIOFREEDOM™ FAMILY stent and other drug eluting stent at the same time * Life-expectancy less than 1 year * Cardiac shock

What they're measuring

Composite event rate of death, non-fatal myocardial infarction (MI), or Target- Vessel Revascularization (TVR)

Timeframe: 1 year

Trial details

NCT IDNCT03190057

SponsorSeung-Jung Park

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-09-29

View on ClinicalTrials.gov More Coronary Stenosis trials